Tiaa, Fsb Amgen Inc Transaction History

Tiaa, Fsb

$27.6 Billion
Q2 2023

A detailed history of Tiaa, Fsb transactions in Amgen Inc stock. As of the latest transaction made, Tiaa, Fsb holds 84,802 shares of AMGN stock, worth $24.1 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

84,802

Previous 89,671 5.43%

Holding current value

$24.1 Million

Previous $21.7 Million 13.15%

% of portfolio

0.07%

Previous 0.08%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$214.27 - $253.37 $1.04 Million - $1.23 Million	-4,869 Reduced 5.43%	84,802 $18.8 Million
Q1 2023 Apr 19, 2023	SELL	$225.79 - $275.2 $600,601 - $732,032	-2,660 Reduced 2.88%	89,671 $21.7 Million
Q4 2022 Jan 12, 2023	SELL	$229.03 - $291.01 $1.06 Million - $1.35 Million	-4,636 Reduced 4.78%	92,331 $24.3 Million
Q3 2022 Oct 11, 2022	SELL	$224.46 - $253.15 $7.95 Million - $8.96 Million	-35,412 Reduced 26.75%	96,967 $21.9 Million
Q2 2022 Aug 09, 2022	BUY	$230.71 - $256.74 $4.95 Million - $5.51 Million	21,464 Added 19.35%	132,379 $32.2 Million
Q1 2022 Apr 13, 2022	BUY	$219.27 - $242.57 $11.5 Million - $12.7 Million	52,324 Added 89.3%	110,915 $26.8 Million
Q4 2021 Feb 01, 2022	BUY	$198.88 - $227.6 $491,233 - $562,172	2,470 Added 4.4%	58,591 $13.2 Million
Q3 2021 Oct 14, 2021	SELL	$212.27 - $248.7 $296,116 - $346,936	-1,395 Reduced 2.43%	56,121 $11.9 Million
Q2 2021 Jul 21, 2021	SELL	$233.58 - $259.14 $63,300 - $70,226	-271 Reduced 0.47%	57,516 $14 Million
Q1 2021 Apr 21, 2021	SELL	$221.91 - $258.6 $845,033 - $984,748	-3,808 Reduced 6.18%	57,787 $14.4 Million
Q4 2020 Jan 21, 2021	SELL	$216.38 - $257.67 $9.14 Million - $10.9 Million	-42,225 Reduced 40.67%	61,595 $14.2 Million
Q3 2020 Oct 13, 2020	SELL	$234.65 - $260.95 $2.12 Million - $2.36 Million	-9,032 Reduced 8.0%	103,820 $26.4 Million
Q2 2020 Jul 15, 2020	BUY	$197.81 - $242.74 $1 Million - $1.23 Million	5,068 Added 4.7%	112,852 $26.6 Million
Q1 2020 Apr 21, 2020	BUY	$182.24 - $241.7 $8.18 Million - $10.8 Million	44,872 Added 71.33%	107,784 $21.9 Million
Q4 2019 Jan 13, 2020	BUY	$189.21 - $243.2 $188,453 - $242,227	996 Added 1.61%	62,912 $15.2 Million
Q3 2019 Oct 08, 2019	BUY	$174.11 - $208.62 $395,403 - $473,776	2,271 Added 3.81%	61,916 $12 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $1.27 Million - $1.49 Million	-7,638 Reduced 11.35%	59,645 $11 Million
Q1 2019 Apr 15, 2019	BUY	$180.87 - $203.88 $39,972 - $45,057	221 Added 0.33%	67,283 $12.8 Million
Q4 2018 Apr 15, 2019	BUY	$178.4 - $208.25 $12 Million - $14 Million	67,062 New	67,062 $13.1 Million
Q4 2018 Feb 22, 2019	SELL	$178.4 - $208.25 $11.7 Million - $13.7 Million	-65,764 Closed	0 $0
Q3 2018 Oct 18, 2018	SELL	$185.29 - $208.89 $246,435 - $277,823	-1,330 Reduced 1.98%	65,764 $13.6 Million
Q2 2018 Jul 20, 2018	SELL	$166.05 - $186.51 $532,522 - $598,137	-3,207 Reduced 4.56%	67,094 $12.4 Million
Q1 2018 Apr 18, 2018	SELL	$169.43 - $198.0 $7.24 Million - $8.46 Million	-42,741 Reduced 37.81%	70,301 $12 Million
Q4 2017 Jan 29, 2018	SELL	$168.79 - $188.59 $416,742 - $465,628	-2,469 Reduced 2.14%	113,042 $19.7 Million
Q3 2017 Oct 24, 2017	BUY	$167.29 - $191.0 $19.3 Million - $22.1 Million	115,511	115,511 $21.5 Million

Others Institutions Holding AMGN

# of Institutions

3,119

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $152B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiaa, Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Tiaa, Fsb with notifications on news.

Account